That's awesome.

False

Informative stuff, thanks for posting

https://ir.dionymed.com/news-events/press-releases/detail/39/dionymed-brands-provides-financing-update-announces

Halted pending news

I believe it is very under the radar also, just look at this board.

"At June 30, 2019, there has only been one tranche for an issuance of 662,252 Units for gross proceeds of $753,750."

"Second Tranche Draw from Alumina Partners (Ontario) Ltd. Capital Commitment 
On July 29, 2019, the Company issued 425,000 Units to Alumina for gross proceeds of $458,621 as part of the second tranche 
draw from Alumina Capital Commitment."


Looks like they are trying to draw as little as possible from the Alumina deal while waiting for the strategic investor or pps to rise. 

"In response to a number of inbounds from potential strategic partners expressing interest in exploring a transaction involving DionyMed, the Company retained a financial advisor to assist in managing these discussions. This review process is coming to a conclusion, and while the Company cannot at this time provide any assurance that a transaction will materialize, the Company expects to provide an update in due course;"

The market cap is closer to 60M, I believe you are leaving out the series a preffered.

They are not taking out 2M tranches from Alumina, if you look at my more recent posts I post the exact amounts from the filings.

They are drawing as little as possible while waiting to close the deal with the strategic investor.

Positive stuff

Expansion of Chill
Since terminating the Eaze relationship, the Company is focusing its efforts on scaling its online delivery platform, Chill, through aggressive
marketing and customer acquisition. Since the Company began to actively market Chill in early April 2019, the Company has increased gross
sales to $855,000 per month as of June 2019, representing an annual run-rate of $10.3 million. Revenues generated through Chill are also
currently generating improved contribution margins relative to revenues earned under the Eaze relationship. The Company expects to
launch chill in Southern California in early 4Q 2019, which will more than double the addressable market.

Looks like they are trying to draw as little as possible from the Alumina deal while waiting for the strategic investor or pps to rise.

In response to a number of inbounds from potential strategic partners expressing interest in exploring a transaction involving DionyMed, the Company retained a financial advisor to assist in managing these discussions. This review process is coming to a conclusion, and while the Company cannot at this time provide any assurance that a transaction will materialize, the Company expects to provide an update in due course;

Second Tranche Draw from Alumina Partners (Ontario) Ltd. Capital Commitment
On July 29, 2019, the Company issued 425,000 Units to Alumina for gross proceeds of $458,621 as part of the second tranche
draw from Alumina Capital Commitment.

At June 30, 2019, there has only been one tranche for an issuance of 662,252 Units for gross proceeds of $753,750.

I wish I paid .77

They terminated the contract with Eaze because Eaze is breaking the law. Had a negative impact on the revenue but long term will force them to build out Chill faster.

https://www.otcmarkets.com/stock/DYMEF/news/DionyMed-Brands-Awarded-Three-Provisional-Licenses-in-Los-Angeles-and-San-Francisco?id=239081

Gotcha. This is from the PR subsequent to Q2

The Company drew additional $2 million from its Inventory Finance Facility and issued a $2 million secured convertible note to Gotham Green Partners.

This is the first mention of them tapping the Alumina deal so I would guess it is the second tranche.

d, “This Agreement provides DionyMed with additional capital to accelerate our cannabis brands distribution and delivery platform. We are continuing to expand our California Direct-To-Consumer footprint with our entry into new markets- Sacramento and Los Angeles- bringing great cannabis brands to consumer throughout the largest cannabis market in the world.”

The alumina deal is the finance they are drawing upon, not toxic but not great.
https://www.businesswire.com/news/home/20190606005861/en/DionyMed-Brands-Announces-Investment-Agreement-CAD32-Million

I don't know what the 24M # is or where you are getting it from.

The Defonce chocolates is a very well known and respected brand also.

Hopefully the strategic partner is well known so we can get some eyeballs on these guys.

"In response to a number of inbounds from potential strategic partners expressing interest in exploring a transaction involving DionyMed, the Company retained a financial advisor to assist in managing these discussions. This review process is coming to a conclusion, and while the Company cannot at this time provide any assurance that a transaction will materialize, the Company expects to provide an update in due course;"

https://ir.dionymed.com/news-events/press-releases/detail/35/dionymed-brands-inc-announces-second-quarter-2019

It's there now... talk of a deal is interesting

More than an ugly day yesterday. Hopefully today will be better.

This is more than a stock it's a company. A company founded in 2017. What's poison about the company.

Lol, I know the feeling. I like the Origin House comparison even better because of the very similar business models and revenues but huge disparity between market caps and I can see it happening in a shorter time frame.

I do believe if you hold it for 5 years you'll get a similar return to what you would have gotten holding canopy/tweed from 2014. I also know this company will still be around in 5 years, they are the real deal, rare for the weed space.

This thing moves on no volume, as evidenced from the fall from 1.30 to .88 all on no volume. It can easily go the other way and then some with some eyeballs.

But I think anything is possible with this stock it moves on so little volume. Only 13M in the float. It could easily run to near 2 on a good q2 report.

DYMEF annual revenue exceeds market cap. Similar business model to Origin House being acquired by Cresco for over $800M. Dionymed Brands did 14.4M last qtr and har a market cap of $50M while Origin House did $21M in revenue last qtr and is being acquired for $800M

DYMEF annual revenue exceeds market cap. Similar business model to Origin House being acquired by Cresco for over $800M. Dionymed Brands did 14.4M last qtr and har a market cap of $50M while Origin House did $21M in revenue last qtr and is being acquired for $800M

DYMEF annual revenue exceeds market cap. Similar business model to Origin House being acquired by Cresco for over $800M. Dionymed Brands did 14.4M last qtr and har a market cap of $50M while Origin House did $21M in revenue last qtr and is being acquired for $800M

I feel like it is definitely under the radar. Then we have the problem that the whole pot sector has been going down to all time new lows for months. Less eyeballs on the sector. Hopefully they report some good stuff along with their q2 report this week but even then I fear that it won't get it started. We need a really good report and/or more eyeballs on the sector. I think it will happen by the end of the year.

Dionymed annual revenue exceeds the market cap. They just expanded to LA and Sacramento. Their business model and revenue is similar to Origin House who is in the process of being acquired by cresco for $800M.

On Dec 31, 2018 there were 52M O/S and around 5.5M warrants and options in the money. Looks like the number I was using was fully diluted!

Now just have to go through the deals in 2019 to figure it out completely. Also get Q2 filings coming next week so will get some confirmation. This is an even better deal than I was thinking!

I am trying to figure it out from the filings but I believe that the 80M is counting in the money options and warrants but that might be wrong and you may be right and the number I am using may be simply fully diluted.

There are 30M shares that come from the 6,000 series F shares

Dymef - hidden gem, 80M mkt cap doing annual revenues of 60M. Similar business model and revenue as ORHOF that is in the process of being acquired by Cresco for $850M.

$1 pps = $80M Mkt cap doing $60M a year in revenue right now. With the new campus in LA they will be doing $80-100M annually by the eoy.

I agree

Right, lost a little revenue because they dropped eaze. Hopefully they come out with big numbers for july and august at the same time.

And Dionymed did 14.4M USD